Celltrion
068270.KS
#736
Rank
โ‚ฌ23.87 B
Marketcap
109,65ย โ‚ฌ
Share price
0.23%
Change (1 day)
-11.06%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): โ‚ฌ0.43 Billion

According to Celltrion 's latest financial reports the company's current earnings are โ‚ฌ2.58 Billion. a decrease over its 2023 earnings that were of โ‚ฌ0.46 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.42 B-8.8%
2023 โ‚ฌ0.46 B6.8%
2022 โ‚ฌ0.43 B-21.85%
2021 โ‚ฌ0.55 B10.25%
2020 โ‚ฌ0.50 B65.16%
2019 โ‚ฌ0.30 B16.64%
2018 โ‚ฌ0.26 B-33.89%
2017 โ‚ฌ0.39 B106.53%
2016 โ‚ฌ0.19 B25.57%
2015 โ‚ฌ0.15 B-6.54%
2014 โ‚ฌ0.16 B47.36%
2013 โ‚ฌ0.11 B-33.63%
2012 โ‚ฌ0.16 B
2010 โ‚ฌ87.24 M72.84%
2009 โ‚ฌ50.47 M260.54%
2008 โ‚ฌ14 M